Avidity Biosciences, Inc.’s Post

#PRKAG2 syndrome is a rare, inherited and progressive cardiac caused by a mutation on the PRKAG2 gene that results in increased AMP-activated protein kinase (AMPK) activity. At Avidity, we are applying the versatility of our AOC™ platform to target the underlying causes of genetic #heartdiseases within precision #cardiology. Building on our advancements in neuromuscular disorders, we’re now expanding our AOC platform to potentially address rare genetic cardiac conditions like PRKAG2 syndrome. Learn more about our lead precision cardiology candidates and the latest innovations in our broader AOC platform in our recent volume: https://lnkd.in/eZ2q7ukX

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics